Astrana Health ROA 2016-2026 | ASTH
Current and historical return on assets (ROA) values for Astrana Health (ASTH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Astrana Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $0.03B | $2.06B | 1.40% |
| 2025-12-31 | $0.02B | $1.81B | 1.22% |
| 2025-09-30 | $0.01B | $1.59B | 0.57% |
| 2025-06-30 | $0.03B | $1.35B | 1.85% |
| 2025-03-31 | $0.04B | $1.31B | 2.68% |
| 2024-12-31 | $0.04B | $1.28B | 3.36% |
| 2024-09-30 | $0.06B | $1.17B | 5.28% |
| 2024-06-30 | $0.07B | $1.12B | 6.07% |
| 2024-03-31 | $0.06B | $1.07B | 5.82% |
| 2023-12-31 | $0.06B | $1.01B | 5.95% |
| 2023-09-30 | $0.04B | $1.02B | 4.33% |
| 2023-06-30 | $0.05B | $0.98B | 4.57% |
| 2023-03-31 | $0.04B | $0.97B | 4.56% |
| 2022-12-31 | $0.05B | $0.94B | 4.77% |
| 2022-09-30 | $0.06B | $0.92B | 6.32% |
| 2022-06-30 | $0.07B | $0.90B | 7.66% |
| 2022-03-31 | $0.07B | $0.89B | 7.90% |
| 2021-12-31 | $0.07B | $0.87B | 7.94% |
| 2021-09-30 | $0.07B | $0.86B | 8.18% |
| 2021-06-30 | $0.05B | $0.84B | 6.29% |
| 2021-03-31 | $0.05B | $0.83B | 5.68% |
| 2020-12-31 | $0.04B | $0.80B | 4.77% |
| 2020-09-30 | $0.04B | $0.78B | 4.52% |
| 2020-06-30 | $0.02B | $0.76B | 2.90% |
| 2020-03-31 | $0.02B | $0.69B | 2.74% |
| 2019-12-31 | $0.02B | $0.64B | 2.34% |
| 2019-09-30 | $0.01B | $0.59B | 0.85% |
| 2019-06-30 | $0.01B | $0.54B | 1.86% |
| 2019-03-31 | $0.01B | $0.52B | 1.72% |
| 2018-12-31 | $0.01B | $0.53B | 2.10% |
| 2018-09-30 | $0.04B | $0.52B | 7.90% |
| 2018-06-30 | $0.04B | $0.38B | 9.97% |
| 2018-03-31 | $0.04B | $0.25B | 14.61% |
| 2017-12-31 | $0.04B | $0.13B | 30.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |